Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.

Stephen Falk, Simon Gollins, John Staffurth, R Ray, Andrew Bridgewater, J Ian Geh, Jane Blazeby, Georgina Griffiths

Research output: Contribution to journal › Article (Academic Journal) › peer-review

33 Citations (Scopus)

267 Downloads (Pure)

Fingerprint Dive into the research topics of 'Long-term results and recurrence patterns from SCOPE-1: a phase II/III randomised trial of definitive chemoradiotherapy +/- cetuximab in oesophageal cancer.'. Together they form a unique fingerprint.